Amneal Pharmaceuticals, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2025
Total Assets: $3.68B
Liabilities Breakdown FY2025
Total Liabilities: $3.75B
Asset Breakdown
Total Assets: $3.68B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $282.0M | 7.7% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $606.3M | 16.5% |
| Property, Plant & Equipment | $443.0M | 12.0% |
| Goodwill | $595.5M | 16.2% |
| Intangible Assets | $563.5M | 15.3% |
| Other Assets | $1.19B | 32.3% |
Liabilities Breakdown
Total Liabilities: $3.75B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $0 | 0.0% |
| Long-Term Debt | $2.57B | 68.4% |
| Other Liabilities | $1.18B | 31.6% |